Nutra Pharma Corp.
NPHC
$0.00
$0.000.00%
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -117.04% | -70.74% | -86.63% | -90.09% | 162.44% |
| Total Depreciation and Amortization | -17.87% | 38.60% | 26.14% | 36.10% | 83.89% |
| Total Amortization of Deferred Charges | -73.46% | -49.16% | -20.31% | 20.14% | 64.64% |
| Total Other Non-Cash Items | 102.45% | 54.27% | 78.40% | 81.82% | -198.79% |
| Change in Net Operating Assets | -70.63% | 220.02% | 274.75% | 530.85% | 1,503.03% |
| Cash from Operations | 27.85% | 55.65% | 58.06% | 57.62% | 56.30% |
| Capital Expenditure | -- | 100.00% | 100.00% | 100.00% | -48.34% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -60.49% | 290.83% | 184.39% | 143.17% | 133.52% |
| Cash from Investing | 329.67% | 310.37% | 153.94% | 131.32% | 109.30% |
| Total Debt Issued | -31.56% | -26.68% | -36.74% | -41.85% | -44.53% |
| Total Debt Repaid | 30.38% | -52.78% | -109.56% | -135.79% | -157.72% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -32.82% | -64.52% | -70.89% | -71.65% | -69.74% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | 100.00% | 74.00% | -232.69% | -199.89% |